Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
8.96 → 9.08 EPS · FY ending Dec 31, 2027 · 5 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for QCRH yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Capital markets revenue reaches at least $60 million by end of 2026 | QCR Holdings aims to grow capital markets revenue to $70 million by end of 2026. | Intact | capital markets revenue falls below $60 million by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
QCRH is a regional financial company with a measured growth thesis, rather than a turnaround story. The long-term thesis is intact, with recent performance in the top half of its industry and a muted price reaction to recent results.
Valuation is above peers, and the expectations gap is modest, suggesting the market’s assumptions are broadly aligned with the evidence. The valuation measure rose recently, but pricing fragility is low and the evidence characterizes the setup as justified.
Near term, loan production is within management’s stated growth range, and capital markets revenue increased in the latest quarter. Expense growth remains below year-to-date revenue growth, though quarterly expenses rose. A guidance cut or lower rates would weigh on the outlook, and the record of a past deep miss adds some execution risk.
Over the next few quarters, the thesis depends on sustaining loan growth, delivering the capital markets revenue range, and keeping expenses disciplined. Guidance cuts or rate cuts are unfavorable scenarios, while continued strong earnings and higher guidance from financial-sector peers could support sector momentum.
For the next 1 to 3 years, QCRH’s thesis is supported by current operating execution, but depends on continued delivery and a rate backdrop that does not weaken the sector. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It has increased its dividend per share from $0.06 to $0.10, showing strong shareholder returns. |
| Intact |
| dividend per share falls below $0.10 in 2026 |
Dividend per share: $0.10 per share FY2026-Q2; GAAP. Published target: >=0.10 USD_PER_SHARE. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 20260.1 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Gross loan growth of 10% to 15% annualized for last three quarters of 2026 | The company targets 10% to 15% annual loan growth for the last three quarters of 2026. | Intact | loan growth falls below 10% annualized in last three quarters of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$8.69 → $9.08 · observed estimates
$0.45B → $0.45B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $8.69 | $449,562,330 | 5 / 3 |
| 2026-07-25 | $8.74 | $451,670,000 | 5 / 3 |
| 2026-07-26 | $8.74 | $451,670,000 | 5 / 3 |
| 2026-07-27 | $8.74 | $451,670,000 | 4 / 2 |
| 2026-07-28 | $8.74 | $451,670,000 | 5 / 3 |
| 2026-07-29 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-07-30 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-07-31 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-08-01 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-02 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-08-03 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-08-04 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-08-05 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-06 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-07 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-08 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-08-09 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-08-10 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-08-12 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-13 | $8.95 | $452,536,670 | 5 / 3 |
| 2026-08-14 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-15 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-16 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-17 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-18 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-19 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-20 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-21 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-22 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-23 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-24 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-25 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-26 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-27 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-28 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-29 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-30 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-08-31 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-01 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-02 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-03 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-04 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-05 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-06 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-07 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-08 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-09 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-10 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-11 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-12 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-13 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-14 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-15 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-16 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-17 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-18 | $8.95 | $452,536,667 | 4 / 2 |
| 2026-09-19 | $8.96 | $451,652,500 | 4 / 2 |
| 2026-09-20 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-21 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-22 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-23 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-24 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-25 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-26 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-27 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-28 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-29 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-09-30 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-10-01 | $8.96 | $451,652,500 | 5 / 2 |
| 2026-10-02 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-03 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-04 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-05 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-06 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-07 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-08 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-09 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-10 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-11 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-12 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-13 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-14 | $8.96 | $452,536,667 | 5 / 3 |
| 2026-10-15 | $8.96 | $452,536,667 | 5 / 2 |
| 2026-10-16 | $8.96 | $452,536,667 | 5 / 3 |
| 2026-10-17 | $8.96 | $452,536,667 | 5 / 3 |
| 2026-10-18 | $8.96 | $452,536,667 | 5 / 3 |
| 2026-10-19 | $8.96 | $452,536,667 | 5 / 3 |
| 2026-10-20 | $8.96 | $452,536,667 | 5 / 3 |
| 2026-10-21 | $8.96 | $452,536,667 | 5 / 3 |
| 2026-10-22 | $9.03 | $452,536,667 | 5 / 3 |
| 2026-10-23 | $9.07 | $451,397,667 | 5 / 3 |
| 2026-10-24 | $9.07 | $451,397,667 | 5 / 2 |
| 2026-10-25 | $9.06 | $451,397,667 | 5 / 2 |
| 2026-10-26 | $9.06 | $451,397,667 | 5 / 3 |
| 2026-10-27 | $9.06 | $451,397,667 | 5 / 3 |
| 2026-10-28 | $9.08 | $451,397,667 | 5 / 3 |
| 2026-10-29 | $9.08 | $451,397,667 | 5 / 3 |
| 2026-10-30 | $9.08 | $451,397,667 | 5 / 3 |
| 2026-10-31 | $9.08 | $451,397,667 | 5 / 3 |
| 2026-11-01 | $9.08 | $451,397,667 | 5 / 3 |
| 2026-11-02 | $9.08 | $451,397,667 | 5 / 3 |
| 2026-11-03 | $9.08 | $451,397,667 | 5 / 3 |
| 2026-11-04 | $9.08 | $451,397,667 | 5 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.